Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 2935, April 1, 2009. Published Online First March 24, 2009;
doi: 10.1158/0008-5472.CAN-08-3458
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-08-3458v1
69/7/2935    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azuma, K.
Right arrow Articles by Inoue, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azuma, K.
Right arrow Articles by Inoue, S.

Endocrinology

Association of Estrogen Receptor {alpha} and Histone Deacetylase 6 Causes Rapid Deacetylation of Tubulin in Breast Cancer Cells

Kotaro Azuma1, Tomohiko Urano1,2, Kuniko Horie-Inoue4, Shin-ichi Hayashi5, Ryuichi Sakai3, Yasuyoshi Ouchi1 and Satoshi Inoue1,2,4

Departments of 1 Geriatric Medicine and 2 Anti-Aging Medicine, Graduate School of Medicine, The University of Tokyo and 3 Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan; 4 Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical School, Saitama, Japan; and 5 Department of Medical Technology, Course of Health Sciences, School of Medicine, Tohoku University, Miyagi, Japan

Requests for reprints: Satoshi Inoue, Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8652; Fax: 81-3-5800-6530; E-mail: INOUE-GER{at}h.u-tokyo.ac.jp.

Key Words: ER{alpha} • breast cancer • HDAC6 • nongenomic action • tubulin

Estrogen receptor {alpha} (ER{alpha}) is a nuclear receptor that functions as a ligand-activated transcription factor. Besides its genomic action in nuclei, ER{alpha} could exert nongenomic actions at the plasma membrane. To investigate the mechanism underlying the nongenomic action of ER{alpha} in breast cancer cells, we generated a construct of membrane-targeted ER{alpha} (memER), an expression vector of ER{alpha} without the nuclear localizing signal and including instead the membrane-targeting sequence of Src kinase. MemER was stably expressed in human breast cancer MCF-7 cells. Cell migration test and tumorigenic assay in nude mice revealed that the in vitro motility and the in vivo proliferation activity of MCF-7 cells expressing memER were significantly enhanced compared with those of vector-transfected cells. Interestingly, the acetylation level of tubulin in memER-overexpressing cells was lower than that in control cells. We found that histone deacetylase (HDAC) 6 translocated to the plasma membrane shortly after estrogen stimulation, and rapid tubulin deacetylation subsequently occurred. We also showed that memER associated with HDAC6 in a ligand-dependent manner. Although tamoxifen is known for its antagonistic role in the ER{alpha} genomic action in MCF-7 cells, the agent showed an agonistic function in the memER-HDAC6 association and tubulin deacetylation. These findings suggest that ER{alpha} ligand dependently forms a complex with HDAC6 and tubulin at the plasma membrane. Estrogen-dependent tubulin deacetylation could provide new evidence for the nongenomic action of estrogen, which potentially contributes to the aggressiveness of ER{alpha}-positive breast cancer cells. [Cancer Res 2009;69(7):2935–40]




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
Y. Zilberman, C. Ballestrem, L. Carramusa, R. Mazitschek, S. Khochbin, and A. Bershadsky
Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6
J. Cell Sci., October 1, 2009; 122(19): 3531 - 3541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.